Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
First Product from Transgenic Animal Cleared in Europe;Mab Associated with Brain Infection Allowed Back on Market;Should U.S. Approve Follow-On Biologics?;D.C. Court of Appeals Finds Constitutional Right to Unapproved Drugs;Participating in Efforts Against Counterfeiters;Specifications Issued for Veterinary Biologics and Biotechnology Products;Electronic Communications Are Desirable for Important Drug Information;Guidance for Antiviral Drug Development;Short Stories: New Indication for Remicade;Bone Stimulant Approved in Canada